Stroke Trial, Recruiting (NCT06494436)

Stroke Trial, Recruiting NCT06494436 Sponsor: Microvention-Terumo, Inc. Condition: Stroke

Printed from Voxsanity (voxsanity.com.au) — NCT06494436 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Stroke

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

The patient, or an authorised representative where allowed by local rules, has been informed about the data collection and has agreed to take part before any data is collected.
For Group 1: People being treated for a brain aneurysm (either one that has burst or one that hasn't) using a specific commercially available MicroVention device, where the treating doctor chose that device independently of this study.
For Group 2: People being treated for a stroke caused by a blood clot, where a commercially available MicroVention clot-removal device is being used as the main treatment, and the treating doctor chose that device independently of this study.

Who may not be able to join:

People who are unlikely to be available for follow-up appointments after treatment.
People who are already taking part in, or planning to join, another study that could affect how the treating site manages care.
People who are already enrolled in this same study (MAESTRO) for the same condition being treated.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 16 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Alejandro Tomasello, MD, University Hospital Vall D'Hebron

Phone: 0033139215220

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06494436

Sponsor: Microvention-Terumo, Inc.

Phase: Not Applicable

Status: Recruiting

Condition: Stroke

Trial contact: 0033139215220

More information: https://clinicaltrials.gov/study/NCT06494436

Eligibility summary (AI generated)

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

The patient, or an authorised representative where allowed by local rules, has been informed about the data collection and has agreed to take part before any data is collected.
For Group 1: People being treated for a brain aneurysm (either one that has burst or one that hasn't) using a specific commercially available MicroVention device, where the treating doctor chose that device independently of this study.
For Group 2: People being treated for a stroke caused by a blood clot, where a commercially available MicroVention clot-removal device is being used as the main treatment, and the treating doctor chose that device independently of this study.

Who may not be able to join:

People who are unlikely to be available for follow-up appointments after treatment.
People who are already taking part in, or planning to join, another study that could affect how the treating site manages care.
People who are already enrolled in this same study (MAESTRO) for the same condition being treated.

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 16 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Microvention-Terumo, Inc.

Registry

ClinicalTrials.gov

Start date

30 December 2024

Est. completion

30 December 2029

Where this trial is recruiting

🇪🇸 Spain

Primary endpoints

Cohort 1: Proportion of aneurysms with complete occlusion; Cohort 2: Proportion of patients achieving final mTICI ≥ 2b revascularization

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 16 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov